Từ khóa hot
Thích
51 phút
+84 Nhận OTP
Tìm mã CK, công ty, tin tức
Theo dõi Doanh nghiệp
So-Young Reports Unaudited Fourth Quarter and Fiscal Year 2024 Financial Results
BEIJING, March 28, 2025 /PRNewswire/ -- So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company"), the leading aesthetic treatment platform in China connecting consumers with online services and offline treatments, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2024.
Fourth Quarter 2024 Financial Highlights
Fourth Quarter 2024 Operational Highlights
Phase (The length of time since establishment) | Number of | Revenue | Average Revenue per |
Ramp-up (0-3 months) | 4 | 2,875,000 | 719,000 |
Growth (4-12 months) | 14 | 64,277,000 | 4,591,000 |
Maturity (over 12 months) | 1 | 14,115,000 | 14,115,000 |
Fiscal Year 2024 Financial Highlights
[1] This press release contains translations of certain Renminbi (RMB) amounts into U.S. dollars (US$) solely for the convenience of the reader. Unless otherwise specified, all translations of Renminbi amounts into U.S. dollar amounts in this press release are made at RMB7.2993 to US$1.00, which was the U.S. dollars middle rate announced by the Board of Governors of the Federal Reserve System of the United States on December 31, 2024. |
[2] Non-GAAP net income/(loss) attributable to So-Young International Inc. is defined as net income/(loss) attributable to So-Young International Inc. excluding share-based compensation expenses, impairment of goodwill attributable to So-Young International Inc., impairment of long-term investment attributable to So-Young International Inc., allowance for credit loss from loans to investees attributable to So-Young International Inc., gain/(loss) on disposal of long-term investment and fair value change of long-term investment attributable to So-Young International Inc., and tax effects on non-GAAP adjustments. See "Reconciliation of GAAP and Non-GAAP Results" at the end of this press release. |
Declaration of Special Dividend
The board of directors of the Company has declared a special cash dividend of US$0.03445 per ordinary share, or US$0.0265 per ADS, to holders of ordinary shares and holders of ADSs of record as of the close of business on April 8, 2025, U.S. Eastern Time, payable in U.S. dollars. The ex-dividend date will be April 8, 2025. The payment date is expected to be on or around April 25, 2025. Dividend to be paid to the Company's ADS holders through the depositary bank will be subject to the terms of the deposit agreement. The total amount of cash to be distributed for the dividend is expected to be approximately US$3 million, which will be funded by surplus cash on the Company's balance sheet.
Mr. Xing Jin, Co-Founder and Chief Executive Officer of So-Young, commented, "Despite a challenging environment, we remain focused on executing our transformation strategy. Our investments in vertical integration and business diversification are beginning to take shape, reinforcing our competitive positioning in the evolving medical aesthetics landscape. The opportunity created by demand for standardized high-quality, cost-effective medical aesthetic products and services remains enormous, one that we are uniquely positioned to capitalize on. As of December 31, 2024, we expanded our network to 19 aesthetic centers across nine major cities, with 11 of them already generating positive operating cash flow. Customer retention rates continue to maintain at approximately 60%, reflecting our ability to maintain the highest levels of customer satisfaction as we scale this proven standardized model nationwide. Our aesthetic treatment services revenues reached RMB81.3 million, marking a 701.6% increase from the same period last year. This substantial growth underscores the traction of our branded aesthetic centers and the strategic rationale behind our transformation efforts. As our upfront investments start to yield returns we expect a more balanced growth trajectory in the coming quarters. We will continue to explore opportunities and deepen the integration across our businesses to enhance operational efficiencies and address industry challenges."
Mr. Hui Zhao, Chief Financial Officer of So-Young, added, "Our fourth-quarter results demonstrate the resilience of our business and strategic agility to adapt to market changes. The expansion of our center network is noticeably improving the customer experience and laying the groundwork for long-term, sustainable growth. We continued to drive operational efficiency improvements, carefully control costs, and invest in scaling and strengthening the synergies between our businesses. While the near-term environment remains dynamic, we are confident that our strategic direction will create long-term value for both our customers and shareholders."
Fourth Quarter 2024 Financial Results
Revenues
Total revenues were RMB369.2 million (US$50.6 million), a decrease of 5.5% from RMB390.6 million in the same period of 2023. The decrease was primarily due to the decrease in revenues generated by So-Young Prime.
Cost of Revenues
Cost of revenues was RMB153.1 million (US$21.0 million), an increase of 11.2% from RMB137.6 million in the fourth quarter of 2023. The increase was primarily due to business extension of the branded aesthetic centers. Cost of revenues included share-based compensation expenses of RMB0.0 million (US$0.0 million), compared with RMB0.2 million in the corresponding period of 2023.
[3] In the fourth quarter of 2024, in light of the better monitoring business development of branded aesthetic centers, the previous line item information services and others was separated into two line items, which are aesthetic treatment services and information services and others. And the Company grouped the revenue generated from information services and others and reservation services, which is renamed as information, reservation services and others. |
The revenue generated from aesthetic treatment services was previously reported in line item of information services and others. The information, reservation services and others for prior periods and the year of 2023 have also been retrospectively updated. The amount reclassified from previous line item information services and others to aesthetic treatment services are RMB81.3 million for the fourth quarter of 2024, RMB10.1 million for the fourth quarter of 2023, RMB169.3 million for the year of 2024, and RMB13.0 million for the year of 2023. |
[4] In the fourth quarter of 2024, the previous line item cost of services and others was separated into two line items, which are cost of aesthetic treatment services and cost of information, reservation services and others. Cost of aesthetic treatment services primarily consists of expenditures relating to aesthetic treatment services in branded aesthetic centers, and the remaining cost of services and others is reclassified into cost of information, reservation services and others. The cost of aesthetic treatment services and cost of information, reservation services and others for prior periods and the year of 2023 have also been retrospectively reclassified. |
Operating Expenses
Total operating expenses were RMB815.2 million (US$111.7 million), an increase of 216.2% from RMB257.8 million in the fourth quarter of 2023.
Income Tax (Expenses)/Benefits
Income tax expenses were RMB2.1 million (US$0.3 million), compared with income tax benefits of RMB10.8 million in the same period of 2023.
Net (Loss)/Income Attributable to So-Young International Inc.
Net loss attributable to So-Young International Inc. was RMB607.6 million (US$83.2 million), compared with a net income attributable to So-Young International Inc. of RMB17.5 million in the fourth quarter of 2023.
Non-GAAP Net (Loss)/Income Attributable to So-Young International Inc.
Non-GAAP net loss attributable to So-Young International Inc., which excludes the impact of share-based compensation expenses, impairment of goodwill attributable to So-Young International Inc., impairment of long-term investment attributable to So-Young International Inc., allowance for credit loss from loans to investees attributable to So-Young International Inc., gain/(loss) on disposal of long-term investment and fair value change of long-term investment attributable to So-Young International Inc., and tax effects on non-GAAP adjustments, was RMB53.2 million (US$7.3 million), compared with RMB35.7 million non-GAAP net income attributable to So-Young International Inc. in the same period of 2023.
Basic and Diluted (Loss)/Earnings per ADS
Basic and diluted loss per ADS attributable to ordinary shareholders were RMB5.92 (US$0.81) and RMB5.92 (US$0.81), respectively, compared with basic and diluted earnings per ADS attributable to ordinary shareholders of RMB0.18 and RMB0.18, respectively, in the same period of 2023.
Fiscal Year 2024 Financial Results
Revenues
Total revenues were RMB1,466.7 million (US$200.9 million), a decrease of 2.1% from RMB1,498.0 million in fiscal year 2023.
Cost of Revenues
Cost of revenues were RMB567.6 million (US$77.8 million), an increase of 4.3% from RMB544.3 million in fiscal year 2023. The increase was primarily due to the business extension of the branded aesthetic centers. In addition, cost of revenues for fiscal year 2024 included share-based compensation expenses of RMB0.3 million (US$0.0 million), compared to RMB1.8 million in fiscal year 2023.
Operating Expenses
Total operating expenses were RMB1,523.6 million (US$208.7 million), an increase of 50.1% from RMB1,014.7 million in fiscal year 2023.
Income Tax Benefits
Income tax benefits were RMB0.9 million (US$0.1 million), compared with an income tax benefits of RMB18.1 million in fiscal year 2023.
Net (Loss)/Income Attributable to So-Young International Inc.
Net loss attributable to So-Young International Inc. was RMB589.5 million (US$80.8 million), compared with a net income attributable to So-Young International Inc. of RMB21.3 million in fiscal year 2023.
Non-GAAP Net (Loss)/Income Attributable to So-Young International Inc.
Non-GAAP net loss attributable to So-Young International Inc., which excludes the impact of share-based compensation expenses, impairment of goodwill attributable to So-Young International Inc., impairment of long-term investment attributable to So-Young International Inc., allowance for credit loss from loans to investees attributable to So-Young International Inc., gain/(loss) on disposal of long-term investment and fair value change of long-term investment attributable to So-Young International Inc., and tax effects on non-GAAP adjustments, was RMB4.7 million (US$0.6 million), compared with a non-GAAP net income attributable to So-Young International Inc. of RMB58.0 million in fiscal year 2023.
Basic and Diluted (Loss)/Earnings per ADS
Basic and diluted loss per ADS attributable to ordinary shareholders were RMB5.72 (US$0.78) and RMB5.72 (US$0.78), respectively, compared with basic and diluted earnings per ADS attributable to ordinary shareholders of RMB0.21 and RMB0.21 in fiscal year 2023.
Cash and Cash Equivalents, Restricted Cash and Term Deposits, Term Deposits and Short-Term Investments
As of December 31, 2024, cash and cash equivalents, restricted cash and term deposits, term deposits and short-term investments were RMB1,253.2 million (US$171.7 million), compared with RMB1,341.6 million as of December 31, 2023.
Business Outlook
For the first quarter of 2025, So-Young expects total revenues to be between RMB280.0 million (US$38.4 million) and RMB300.0 million (US$41.1 million), representing a 12.0% to 5.7% decrease from the same period in 2024. The above outlook is based on the current market conditions and reflects the Company's preliminary estimates of market and operating conditions, as well as customer demand, which are all subject to change.
Non-GAAP Financial Measures
To supplement the financial measures prepared in accordance with generally accepted accounting principles in the United States, or GAAP, this press release presents non-GAAP income/(loss) from operations and non-GAAP net income/(loss) attributable to So-Young International Inc. by excluding share-based compensation expenses and impairment of goodwill from income/(loss) from operations, and excluding share-based compensation expenses, impairment of goodwill, impairment of long-term investment, allowance for credit loss from loans to investees, gain/(loss) on disposal of long-term investment and fair value change of long-term investment and tax effects on non-GAAP adjustments from net income/(loss) attributable to So-Young International Inc., respectively. Starting from the fourth quarter of 2024, the Company newly included impairment of long-term investment, allowance for credit loss from loans to investees, gain/(loss) on disposal of long-term investment and fair value change of long-term investment and tax effects on non-GAAP adjustments as additional adjustments in its non-GAAP financial measures, which may result in differences from previously disclosed non-GAAP figures.
The Company believes these non-GAAP financial measures are important to help investors understand the Company's operating and financial performance, compare business trends among different reporting periods on a consistent basis and assess the Company's core operating results, as they exclude certain expenses (i) that are not expected to result in cash payments or (ii) that are non-recurring in nature or may not be indicative of the Company's core operating results and business outlook. The use of the above non-GAAP financial measures has certain limitations. Share-based compensation expenses, the impairment of goodwill, impairment of long-term investment and allowance for credit loss from loans to investees are non-cash in nature. Gain/(loss) on disposal of long-term investment and fair value change of long-term investment are non-recurring in nature. And, in substance, both impairment of long-term investment and allowance for credit loss from loans to investees are impairment of investment. All these are not reflected in the presentation of the non-GAAP financial measures, but should be considered in the overall evaluation of the Company's results. The Company compensates for these limitations by providing the relevant disclosure of its share-based compensation expenses, impairment of goodwill, impairment of long-term investment, allowance for credit loss from loans to investees, gain/(loss) on disposal of long-term investment and fair value change of long-term investment and tax effects on non-GAAP adjustments in the reconciliations to the most directly comparable GAAP financial measures, which should be considered when evaluating the Company's performance. These non-GAAP financial measures should be considered in addition to financial measures prepared in accordance with GAAP, but should not be considered a substitute for, or superior to, financial measures prepared in accordance with GAAP. Reconciliation of each of these non-GAAP financial measures to the most directly comparable GAAP financial measure is set forth at the end of this release.
Conference Call Information
So-Young's management will hold an earnings conference call on Friday, March 28, 2025, at 7:30 AM U.S. Eastern Time (7:30 PM on the same day, Beijing/Hong Kong Time). Dial-in details for the earnings conference call are as follows:
International: | +1-412-902-4272 |
Mainland China： | 4001-201203 |
US: | +1-888-346-8982 |
Hong Kong： | +852-301-84992 |
Passcode: | So-Young International Inc. |
A telephone replay will be available two hours after the conclusion of the conference call through 23:59 U.S. Eastern Time, April 4, 2025. The dial-in details are:
International: | +1-412-317-0088 |
US: | +1-877-344-7529 |
Passcode: | 8460187 |
Additionally, a live and archived webcast of this conference call will be available at http://ir.soyoung.com.
About So-Young International Inc.
So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company") is the leading aesthetic treatment platform in China connecting consumers with online services and offline treatments. The Company provides access to aesthetic treatments through its online platform and branded aesthetic centers, offering curated treatment information, facilitating online reservations, delivering high-quality treatments, and developing, producing and distributing optoelectronic medical equipment and injectable products. With its strong brand recognition, digital reach, affordable treatments and efficient supply chain, So-Young is well-positioned to serve its audience over the long term and grow along the medical aesthetic value chain.
Safe Harbor Statement
This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," "confident" and similar statements. Among other things, the Financial Guidance and quotations from management in this announcement, as well as So-Young's strategic and operational plans, contain forward-looking statements. So-Young may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission, in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including but not limited to statements about So-Young's beliefs and expectations, are forward-looking statements. Forward looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: So-Young's strategies; So-Young's future business development, financial condition and results of operations; So-Young's ability to retain and increase the number of users and medical service providers, and expand its service offerings; competition in the online medical aesthetic service industry; changes in So-Young's revenues, costs or expenditures; Chinese governmental policies and regulations relating to the online medical aesthetic service industry, general economic and business conditions globally and in China; and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks is included in the Company's filings with the Securities and Exchange Commission. All information provided in this press release and in the attachments is as of the date of the press release, and So-Young undertakes no duty to update such information, except as required under applicable law.
For more information, please contact:
So-Young
Investor Relations
Ms. Mona Qiao
Phone: +86-10-8790-2012
E-mail: ir@soyoung.com
Ms. Mona Qiao
Phone: +86-10-8790-2012
E-mail: ir@soyoung.com
Christensen
In China
Ms. Dee Wang
Phone: +86-10-5900-1548
E-mail: dee.wang@christensencomms.com
Ms. Dee Wang
Phone: +86-10-5900-1548
E-mail: dee.wang@christensencomms.com
In US
Ms. Linda Bergkamp
Phone: +1-480-614-3004
Email: linda.bergkamp@christensencomms.com
Phone: +1-480-614-3004
Email: linda.bergkamp@christensencomms.com
SO-YOUNG INTERNATIONAL INC. UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Amounts in thousands, except for share and per share data) | |||||
As of | |||||
December 31, | December 31, | December 31, | |||
2023 | 2024 | 2024 | |||
RMB | RMB | US$ | |||
Assets | |||||
Current assets: | |||||
Cash and cash equivalents | 426,119 | 587,749 | 80,521 | ||
Restricted cash and term deposits | 14,695 | 66,367 | 9,092 | ||
Trade receivables | 57,219 | 98,774 | 13,532 | ||
Inventories | 118,924 | 151,754 | 20,790 | ||
Receivables from online payment platforms | 23,158 | 24,255 | 3,323 | ||
Amounts due from related parties | 9,212 | 1,218 | 167 | ||
Term deposits and short-term investments | 900,823 | 599,041 | 82,068 | ||
Prepayment and other current assets | 171,774 | 195,202 | 26,743 | ||
Total current assets | 1,721,924 | 1,724,360 | 236,236 | ||
Non-current assets: | |||||
Long-term investments | 261,016 | 280,281 | 38,398 | ||
Intangible assets | 145,253 | 126,615 | 17,346 | ||
Goodwill | 540,693 | 684 | 94 | ||
Property and equipment, net | 116,782 | 155,352 | 21,283 | ||
Deferred tax assets | 78,034 | 84,950 | 11,638 | ||
Operating lease right-of-use assets | 118,408 | 162,764 | 22,299 | ||
Other non-current assets | 232,455 | 200,152 | 27,421 | ||
Total non-current assets | 1,492,641 | 1,010,798 | 138,479 | ||
Total assets | 3,214,565 | 2,735,158 | 374,715 | ||
Liabilities | |||||
Current liabilities: | |||||
Short-term borrowings | 29,825 | 69,771 | 9,559 | ||
Taxes payable | 56,894 | 61,862 | 8,475 | ||
Contract liabilities | 103,374 | 76,579 | 10,491 | ||
Salary and welfare payables | 86,290 | 111,396 | 15,261 | ||
Amounts due to related parties | 388 | 477 | 65 | ||
Accrued expenses and other current liabilities | 233,913 | 265,216 | 36,334 | ||
Operating lease liabilities-current | 29,739 | 44,905 | 6,152 | ||
Total current liabilities | 540,423 | 630,206 | 86,337 | ||
Non-current liabilities: | |||||
Operating lease liabilities-non current | 86,210 | 125,200 | 17,152 | ||
Deferred tax liabilities | 25,082 | 19,758 | 2,707 | ||
Other non-current liabilities | 1,536 | 1,264 | 173 | ||
Total non-current liabilities | 112,828 | 146,222 | 20,032 | ||
Total liabilities | 653,251 | 776,428 | 106,369 | ||
SO-YOUNG INTERNATIONAL INC. UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Continued) (Amounts in thousands, except for share and per share data) | ||||||
Shareholders' equity: | ||||||
Treasury stock | (358,453) | (376,690) | (51,606) | |||
Class A ordinary shares (US$0.0005 par value; 750,000,000 | 238 | 253 | 35 | |||
Class B ordinary shares (US$ 0.0005 par value; 20,000,000 | 37 | 37 | 5 | |||
Additional paid-in capital | 3,080,433 | 3,069,799 | 420,561 | |||
Statutory reserves | 33,855 | 40,552 | 5,556 | |||
Accumulated deficit | (330,166) | (926,390) | (126,915) | |||
Accumulated other comprehensive income | 18,185 | 31,560 | 4,324 | |||
Total So-Young International Inc. shareholders' equity | 2,444,129 | 1,839,121 | 251,960 | |||
Non-controlling interests | 117,185 | 119,609 | 16,386 | |||
Total shareholders' equity | 2,561,314 | 1,958,730 | 268,346 | |||
Total liabilities and shareholders' equity | 3,214,565 | 2,735,158 | 374,715 | |||
SO-YOUNG INTERNATIONAL INC. UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Amounts in thousands, except for share and per share data) | ||||||||||||
For the Three Months Ended | For the Fiscal Year Ended | |||||||||||
December 31, 2023 | December 31, 2024 | December 31, 2024 | December 31, 2023 | December 31, 2024 | December 31, 2024 | |||||||
RMB | RMB | US$ | RMB | RMB | US$ | |||||||
Revenues: | ||||||||||||
Information, reservation services and others | 278,529 | 201,512 | 27,607 | 1,151,532 | 929,455 | 127,335 | ||||||
Aesthetic treatment services | 10,138 | 81,267 | 11,134 | 12,959 | 169,263 | 23,189 | ||||||
Sales of medical products and maintenance services | 101,899 | 86,432 | 11,841 | 333,538 | 367,980 | 50,413 | ||||||
Total revenues | 390,566 | 369,211 | 50,582 | 1,498,029 | 1,466,698 | 200,937 | ||||||
Cost of revenues: | ||||||||||||
Cost of information, reservation services and others | (85,951) | (44,518) | (6,099) | (375,986) | (252,841) | (34,639) | ||||||
Cost of aesthetic treatment services | (8,128) | (65,208) | (8,933) | (9,596) | (131,580) | (18,026) | ||||||
Cost of medical products sold and maintenance services | (43,555) | (43,325) | (5,936) | (158,754) | (183,164) | (25,093) | ||||||
Total cost of revenues | (137,634) | (153,051) | (20,968) | (544,336) | (567,585) | (77,758) | ||||||
Gross profit | 252,932 | 216,160 | 29,614 | 953,693 | 899,113 | 123,179 | ||||||
Operating expenses: | ||||||||||||
Sales and marketing expenses | (126,175) | (134,045) | (18,364) | (520,451) | (494,493) | (67,745) | ||||||
General and administrative expenses | (86,668) | (98,420) | (13,483) | (290,765) | (324,073) | (44,398) | ||||||
Research and development expenses | (44,993) | (42,753) | (5,857) | (203,524) | (165,030) | (22,609) | ||||||
Impairment of goodwill | — | (540,009) | (73,981) | — | (540,009) | (73,981) | ||||||
Total operating expenses | (257,836) | (815,227) | (111,685) | (1,014,740) | (1,523,605) | (208,733) | ||||||
Loss from operations | (4,904) | (599,067) | (82,071) | (61,047) | (624,492) | (85,554) | ||||||
Other income/(expenses): | ||||||||||||
Investment income, net | 1,135 | 7,623 | 1,044 | 12,004 | 11,020 | 1,510 | ||||||
Interest income, net | 10,820 | 8,237 | 1,128 | 48,843 | 46,507 | 6,371 | ||||||
Exchange gains/(losses) | 389 | (763) | (105) | (662) | 112 | 15 | ||||||
Impairment of long-term investment | (444) | (7,350) | (1,007) | (444) | (7,350) | (1,007) | ||||||
Share of losses of equity method investee | (2,031) | (3,413) | (468) | (12,723) | (15,015) | (2,057) | ||||||
Others, net | 3,424 | (11,103) | (1,521) | 21,898 | 1,131 | 155 | ||||||
Income/(Loss) before tax | 8,389 | (605,836) | (83,000) | 7,869 | (588,087) | (80,567) | ||||||
Income tax benefits/(expenses) | 10,835 | (2,126) | (291) | 18,075 | 905 | 124 | ||||||
Net income/(loss) | 19,224 | (607,962) | (83,291) | 25,944 | (587,182) | (80,443) | ||||||
Net (income)/loss attributable to noncontrolling interests | (1,723) | 386 | 53 | (4,664) | (2,345) | (321) | ||||||
Net income/(loss) attributable to So-Young International Inc. | 17,501 | (607,576) | (83,238) | 21,280 | (589,527) | (80,764) | ||||||
SO-YOUNG INTERNATIONAL INC. UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Continued) (Amounts in thousands, except for share and per share data)
| ||||||||||||
For the Three Months Ended | For the Fiscal Year Ended | |||||||||||
December | December | December | December | December | December | |||||||
RMB | RMB | US$ | RMB | RMB | US$ | |||||||
Net earnings/(loss) per ordinary share | ||||||||||||
Net earnings/(loss) per ordinary share attributable to ordinary shareholder - basic | 0.23 | (7.70) | (1.05) | 0.27 | (7.43) | (1.02) | ||||||
Net earnings/(loss) per ordinary share attributable to ordinary shareholder - | 0.23 | (7.70) | (1.05) | 0.27 | (7.43) | (1.02) | ||||||
Net earnings/(loss) per ADS attributable to ordinary shareholders - basic (13 | 0.18 | (5.92) | (0.81) | 0.21 | (5.72) | (0.78) | ||||||
Net earnings/(loss) per ADS attributable to ordinary shareholders - diluted (13 | 0.18 | (5.92) | (0.81) | 0.21 | (5.72) | (0.78) | ||||||
Weighted average number of ordinary shares used in computing earnings/(loss) | 76,584,151 | 78,905,617 | 78,905,617 | 77,646,899 | 79,384,454 | 79,384,454 | ||||||
Weighted average number of ordinary shares used in computing earnings/(loss) | 77,011,890 | 78,905,617 | 78,905,617 | 78,054,950 | 79,384,454 | 79,384,454 | ||||||
Share-based compensation expenses included in: | ||||||||||||
Cost of revenues | (165) | (34) | (5) | (1,800) | (289) | (40) | ||||||
Sales and marketing expenses | (2,830) | (239) | (33) | (5,680) | (659) | (90) | ||||||
General and administrative expenses | (13,190) | (1,731) | (237) | (23,590) | (29,527) | (4,045) | ||||||
Research and development expenses | (1,615) | (211) | (29) | (5,251) | (2,180) | (299) | ||||||
* Both Class A and Class B ordinary shares are included in the calculation of the weighted average number of ordinary shares outstanding, basic and diluted. |
SO-YOUNG INTERNATIONAL INC. Reconciliation of GAAP and Non-GAAP Results (Amounts in thousands, except for share and per share data) | ||||||||||||
For the Three Months Ended | For the Fiscal Year Ended | |||||||||||
December | December | December | December | December | December | |||||||
RMB | RMB | US$ | RMB | RMB | US$ | |||||||
GAAP loss from operations | (4,904) | (599,067) | (82,071) | (61,047) | (624,492) | (85,554) | ||||||
Add back: Share-based compensation expenses | 17,800 | 2,215 | 304 | 36,321 | 32,655 | 4,474 | ||||||
Add back: Impairment of goodwill | — | 540,009 | 73,981 | — | 540,009 | 73,981 | ||||||
Non-GAAP income/(loss) from operations | 12,896 | (56,843) | (7,786) | (24,726) | (51,828) | (7,099) | ||||||
GAAP net income/(loss) attributable to So-Young International Inc. | 17,501 | (607,576) | (83,238) | 21,280 | (589,527) | (80,764) | ||||||
Add back: Share-based compensation expenses | 17,800 | 2,215 | 304 | 36,321 | 32,655 | 4,474 | ||||||
Add back: Impairment of goodwill attributable to So-Young International Inc. | — | 540,009 | 73,981 | — | 540,009 | 73,981 | ||||||
Add back: Impairment of long-term investment attributable to So-Young | 444 | 7,350 | 1,007 | 444 | 7,350 | 1,007 | ||||||
Add back: Allowance for credit loss from loans to investees attributable to So- | — | 13,843 | 1,896 | — | 13,843 | 1,896 | ||||||
Reversal: Gain on disposal of long-term investment and fair value change of | — | (7,791) | (1,067) | — | (7,791) | (1,067) | ||||||
Reversal: Tax effects on non-GAAP adjustments (1) | — | (1,276) | (175) | — | (1,276) | (175) | ||||||
Non-GAAP net income/(loss) attributable to So-Young International Inc. | 35,745 | (53,226) | (7,292) | 58,045 | (4,737) | (648) | ||||||
(1) To adjust the income tax effects of non-GAAP adjustments, which is primarily related to allowance for credit loss from loans to investees, gain/(loss) on disposal of long-term investment and fair value change of long-term investment. Other non-GAAP adjustment items have no tax effect, because full valuation allowances were provided for related deferred tax assets as it is more-likely-than-not they will not be realized. |
Thích
Bình luận
Chia sẻ
2 giờ
2 giờ
3 giờ
3 giờ
3 giờ
3 giờ
3 giờ
3 giờ
4 giờ
